Correlation Between RenovoRx and Tff Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Tff Pharmaceuticals, you can compare the effects of market volatilities on RenovoRx and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Tff Pharmaceuticals.
Diversification Opportunities for RenovoRx and Tff Pharmaceuticals
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between RenovoRx and Tff is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of RenovoRx i.e., RenovoRx and Tff Pharmaceuticals go up and down completely randomly.
Pair Corralation between RenovoRx and Tff Pharmaceuticals
Given the investment horizon of 90 days RenovoRx is expected to generate 0.24 times more return on investment than Tff Pharmaceuticals. However, RenovoRx is 4.17 times less risky than Tff Pharmaceuticals. It trades about 0.36 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.33 per unit of risk. If you would invest 98.00 in RenovoRx on August 29, 2024 and sell it today you would earn a total of 38.00 from holding RenovoRx or generate 38.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Tff Pharmaceuticals
Performance |
| Timeline |
| RenovoRx |
| Tff Pharmaceuticals |
RenovoRx and Tff Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Tff Pharmaceuticals
The main advantage of trading using opposite RenovoRx and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.| RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
| Tff Pharmaceuticals vs. Gain Therapeutics | Tff Pharmaceuticals vs. In8bio Inc | Tff Pharmaceuticals vs. Lantern Pharma | Tff Pharmaceuticals vs. INmune Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |